Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1

Cancer Cell(2021)10.1016/j.ccell.2021.11.002Source: DataRank Database

The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1 is a research paper published in Cancer Cell (2021). On theSindex it has a DataRank of 0. It has been cited 310 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access310 citations

Download PDF

Cite:

Linked data & code

geo bioproject gen cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 15.54)OA: bronzeTopics (33)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (20)

Yi Xiao ORCID,Qin Li ORCID,Jun Yao ORCID,Xiangliang Yuan ORCID,Yuan Zhang ORCID

Live enrichment

PubMed:34822775 PMC:PMC8779329 OpenAlex:https://openalex.org/W3215077655

National Institutes of Health

Grant: 56675

National Institutes of Health

Grant: 58284

National Institutes of Health

Grant: R01CA112567

National Institutes of Health

Grant: R01CA184836

National Institutes of Health

Grant: R01CA208213

NCI

Grant: P30CA016672

Cancer Prevention and Research Institute of Texas

Grant: RP180734

METAvivor

FWCI

15.54

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S1535610821006024/pdf

publisherhttp://www.cell.com/article/S1535610821006024/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535610821006024?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535610821006024?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ccell.2021.11.002

Fields of Study

Immune Cell Function and InteractionMast cells and histamineImmunotherapy and Immune Responses

MeSH Terms

HistamineHumansImmune ToleranceImmunotherapyMacrophagesNeoplasmsReceptors, HistamineCell Line, TumorTumor Microenvironment

Keywords

HistamineImmunotherapyImmunologyMedicineCancer immunotherapyAntihistamineHistamine H4 receptorTumor microenvironmentImmune systemHistamine H1 receptorAllergyCancer researchCancerPharmacologyReceptorInternal medicineHistamine H2 receptorMacrophageImmune EvasionT Cell DysfunctionHrh1

Sustainable Development Goals

SDG 0: Good health and well-being